Kwmg LLC decreased its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 2.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 122,145 shares of the company’s stock after selling 3,615 shares during the period. Cardinal Health comprises 1.5% of Kwmg LLC’s holdings, making the stock its 17th largest holding. Kwmg LLC owned approximately 0.05% of Cardinal Health worth $14,446,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in the company. Paragon Capital Management Inc. raised its holdings in Cardinal Health by 0.7% during the second quarter. Paragon Capital Management Inc. now owns 14,758 shares of the company’s stock worth $1,451,000 after purchasing an additional 99 shares in the last quarter. Huntington National Bank increased its position in Cardinal Health by 0.9% during the 3rd quarter. Huntington National Bank now owns 10,792 shares of the company’s stock worth $1,193,000 after purchasing an additional 100 shares during the period. Blair William & Co. IL increased its position in Cardinal Health by 0.9% during the 2nd quarter. Blair William & Co. IL now owns 11,442 shares of the company’s stock worth $1,125,000 after purchasing an additional 103 shares during the period. Frazier Financial Advisors LLC raised its stake in shares of Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after buying an additional 104 shares in the last quarter. Finally, UMB Bank n.a. lifted its holdings in shares of Cardinal Health by 4.9% in the 3rd quarter. UMB Bank n.a. now owns 2,249 shares of the company’s stock valued at $249,000 after buying an additional 106 shares during the period. 87.17% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of research analysts recently weighed in on the company. Wells Fargo & Company raised Cardinal Health from an “underweight” rating to an “equal weight” rating and upped their price objective for the stock from $101.00 to $127.00 in a report on Friday, December 13th. StockNews.com cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Citigroup raised their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday. Evercore ISI raised shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a report on Tuesday, January 7th. Finally, UBS Group increased their target price on shares of Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a report on Monday, November 4th. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average target price of $133.29.
Cardinal Health Trading Down 0.6 %
Shares of NYSE CAH traded down $0.70 during trading on Monday, reaching $120.87. The company had a trading volume of 913,384 shares, compared to its average volume of 2,046,463. The stock has a market capitalization of $29.25 billion, a PE ratio of 23.52, a price-to-earnings-growth ratio of 1.47 and a beta of 0.63. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $126.23. The stock has a 50-day moving average price of $119.88 and a two-hundred day moving average price of $111.08.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its earnings results on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The firm had revenue of $52.28 billion during the quarter, compared to the consensus estimate of $50.90 billion. During the same quarter in the previous year, the company posted $1.73 EPS. The firm’s revenue for the quarter was down 4.3% on a year-over-year basis. On average, sell-side analysts predict that Cardinal Health, Inc. will post 7.82 EPS for the current year.
Cardinal Health Cuts Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a $0.5056 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $2.02 annualized dividend and a yield of 1.67%. Cardinal Health’s payout ratio is currently 39.30%.
Cardinal Health Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
- Five stocks we like better than Cardinal Health
- What is the S&P 500 and How It is Distinct from Other Indexes
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- The How and Why of Investing in Gold Stocks
- Delta Can Fly to New Highs in 2025; Here’s Why
- Investing In Preferred Stock vs. Common Stock
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.